Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gábor Földes, Stephan von Haehling & Stefan D Anker. (2006) Toll-like receptor modulation in cardiovascular disease: a target for intervention?. Expert Opinion on Investigational Drugs 15:8, pages 857-871.
Read now
Read now
Articles from other publishers (28)
Kenny Kuchta & Silke Cameron. (2020) Phytotherapy for Cachexia: Where Do We Stand?. Frontiers in Pharmacology 11.
Crossref
Crossref
Nicole Ebner, Gabor Földes, Lutz Schomburg, Kostja Renko, Jochen Springer, Ewa A. Jankowska, Rakesh Sharma, Sabine Genth-Zotz, Wolfram Doehner, Stefan D. Anker & Stephan von Haehling. (2015) Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure. Journal of Molecular and Cellular Cardiology 87, pages 48-53.
Crossref
Crossref
Nicole Ebner, Jochen Springer, Kamyar Kalantar-Zadeh, Mitja Lainscak, Wolfram Doehner, Stefan D. Anker & Stephan von Haehling. (2013) Mechanism and novel therapeutic approaches to wasting in chronic disease. Maturitas 75:3, pages 199-206.
Crossref
Crossref
Norman Mangner, Yae Matsuo, Gerhard Schuler & Volker Adams. (2012) Cachexia in chronic heart failure: endocrine determinants and treatment perspectives. Endocrine 43:2, pages 253-265.
Crossref
Crossref
Rajat Sethi, Shubham Manchanda, Rama Surya Prakash Perepu, Ajay Kumar, Carlos Garcia, Richard H. Kennedy, Srinath Palakurthi & David Dostal. (2012) Differential expression of caveolin-1 and caveolin-3: potential marker for cardiac toxicity subsequent to chronic ozone inhalation. Molecular and Cellular Biochemistry 369:1-2, pages 9-15.
Crossref
Crossref
Stephan von Haehling, Joerg C. Schefold, Ewa A. Jankowska, Jochen Springer, Ali Vazir, Paul R. Kalra, Anja Sandek, Günter Fauler, Tatjana Stojakovic, Michael Trauner, Piotr Ponikowski, Hans-Dieter Volk, Wolfram Doehner, Andrew J.S. Coats, Philip A. Poole-Wilson & Stefan D. Anker. (2012) Ursodeoxycholic Acid in Patients With Chronic Heart Failure. Journal of the American College of Cardiology 59:6, pages 585-592.
Crossref
Crossref
Philipp Attanasio, Stefan D Anker, Wolfram Doehner & Stephan von Haehling. (2011) Hormonal consequences and prognosis of chronic heart failure. Current Opinion in Endocrinology, Diabetes & Obesity 18:3, pages 224-230.
Crossref
Crossref
Wolfram Doehner, Stephan von Haehling,Stefan D. Anker. 2011. Heart Failure: A Companion to Braunwald's Heart Disease. Heart Failure: A Companion to Braunwald's Heart Disease
330
345
.
Stephan von Haehling, Ralph S. von Bardeleben, Thorsten Kramm, Yardena Thiermann, Margit Niethammer, Wolfram Doehner, Stefan D. Anker, Thomas Munzel, Eckhard Mayer & Sabine Genth-Zotz. (2010) Inflammation in right ventricular dysfunction due to thromboembolic pulmonary hypertension. International Journal of Cardiology 144:2, pages 206-211.
Crossref
Crossref
Wolfram Doehner & Stefan D. Anker. 2010. Heart Failure in Clinical Practice. Heart Failure in Clinical Practice
165
185
.
G?bor F?ldes, Stefan D. Anker & Stephan von Haehling. (2009) Atorvastatin Modulates Th1/Th2 Response in Patients With Chronic Heart Failure. Journal of Cardiac Failure 15:6, pages 551.
Crossref
Crossref
Stephan von Haehling, Joerg C. Schefold, Ewa Jankowska, Wolfram Doehner, Jochen Springer, Kristin Strohschein, Sabine Genth-Zotz, Hans-Dieter Volk, Philip Poole-Wilson & Stefan D. Anker. (2009) Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure. PLoS ONE 4:7, pages e6411.
Crossref
Crossref
Stephan von Haehling, Nicholas S. Hopkinson, Michael I. Polkey, Margit Niethammer, Stefan D. Anker & Sabine Genth-Zotz. (2009) Elevated TNFα production in whole blood in patients with severe COPD: the potential link to disease severity. Wiener klinische Wochenschrift 121:9-10, pages 303-308.
Crossref
Crossref
Stephan von Haehling, Mitja Lainscak, Jochen Springer & Stefan D. Anker. (2009) Cardiac cachexia: A systematic overview. Pharmacology & Therapeutics 121:3, pages 227-252.
Crossref
Crossref
Mitja Lainscak, Stephan von Haehling & Stefan D. Anker. (2009) Natriuretic peptides and other biomarkers in chronic heart failure: From BNP, NT-proBNP, and MR-proANP to routine biochemical markers. International Journal of Cardiology 132:3, pages 303-311.
Crossref
Crossref
Stephan von Haehling. (2008) Statins for heart failure: still caught in no man's land?. Clinical Science 116:1, pages 37-39.
Crossref
Crossref
Anja Sandek, Mathias Rauchhaus, Stefan D Anker & Stephan von Haehling. (2008) The emerging role of the gut in chronic heart failure. Current Opinion in Clinical Nutrition & Metabolic Care 11:5, pages 632-639.
Crossref
Crossref
Kamyar Kalantar-Zadeh, Stefan D. Anker, Tamara B. Horwich & Gregg C. Fonarow. (2008) Nutritional and Anti-Inflammatory Interventions in Chronic Heart Failure. The American Journal of Cardiology 101:11, pages S89-S103.
Crossref
Crossref
Stephan von Haehling, Joerg C. Schefold, Jochen Springer & Stefan D. Anker. (2008) The Cholesterol Paradox Revisited: Heart Failure, Systemic Inflammation, and Beyond. Heart Failure Clinics 4:2, pages 141-151.
Crossref
Crossref
G?bor F?ldes, Stephan von Haehling, Darlington O. Okonko, Ewa A. Jankowska, Philip A. Poole-Wilson & Stefan D. Anker. (2008) Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure. International Journal of Cardiology 124:1, pages 80-85.
Crossref
Crossref
Ayman A. El-Menyar. (2008) Cytokines and Myocardial Dysfunction: State of the Art. Journal of Cardiac Failure 14:1, pages 61-74.
Crossref
Crossref
Cécile Moro, Marie-Gabrielle Jouan, Andry Rakotovao, Marie-Claire Toufektsian, Olivier Ormezzano, Norbert Nagy, Arpad Tosaki, Joël de Leiris & François Boucher. (2007) Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling. American Journal of Physiology-Heart and Circulatory Physiology 293:5, pages H3014-H3019.
Crossref
Crossref
M. Hartford, O. Wiklund, L. Mattsson Hult?n, A. Persson, T. Karlsson, J. Herlitz & K. Caidahl. (2007)
C-reactive protein, interleukin-6, secretory phospholipase A
2
group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes
. Journal of Internal Medicine 262:5, pages 526-536.
Crossref
Crossref
Stephan von Haehling, Ewa A. Jankowska, Nils G. Morgenthaler, Corrado Vassanelli, Luisa Zanolla, Piotr Rozentryt, Gerasimos S. Filippatos, Wolfram Doehner, Friedrich Koehler, Jana Papassotiriou, Dimitrios T. Kremastinos, Waldemar Banasiak, Joachim Struck, Piotr Ponikowski, Andreas Bergmann & Stefan D. Anker. (2007) Comparison of Midregional Pro-Atrial Natriuretic Peptide With N-Terminal Pro-B-Type Natriuretic Peptide in Predicting Survival in Patients With Chronic Heart Failure. Journal of the American College of Cardiology 50:20, pages 1973-1980.
Crossref
Crossref
Arturo Orea-Tejeda, Oscar Arrieta-Rodríguez, Lilia Castillo-Martínez, Tatiana Rodríguez-Reyna, Enrique Asensio-Lafuente, Julio Granados-Arriola & Joel Dorantes-García. (2007) Effects of Thalidomide Treatment in Heart Failure Patients. Cardiology 108:4, pages 237-242.
Crossref
Crossref
Sabine Genth-Zotz, Stephan von Haehling, Aidan P. Bolger, Paul R. Kalra, Roland Wensel, Andrew J.S. Coats, Hans-Dieter Volk & Stefan D. Anker. (2006) The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure. European Journal of Heart Failure 8:4, pages 366-372.
Crossref
Crossref
S. Haehling, W. Doehner & S. D. Anker. 2006. Chronic Viral and Inflammatory Cardiomyopathy. Chronic Viral and Inflammatory Cardiomyopathy
155
168
.
P Sarzi-PuttiniF Atzeni, A Doria, L Iaccarino & M Turiel. (2016) Tumor necrosis factor-a, biologic agents and cardiovascular risk. Lupus 14:9, pages 780-784.
Crossref
Crossref